Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
CatSci
CatSci
Activities:
Research & Development
X
LinkedIn
Trending Articles
IMPACT CKD model reveals the escalating toll of chronic kidney disease
The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Isospec Analytics launches biomolecular analysis technology to identify unknown molecules
The novel technology optimises the identification process of unknown molecules compared to mass analysis
Building strong foundations for a resilient and planet-friendly future
Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector
The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
CatSci wins Welsh government SMART Capital Equipment Grant for oligonucleotide development
CatSci has won a Welsh Government SMART Capital Equipment Fund grant to enhance their oligonucleotides capability and offer more and better R&D and manufacturing solutions to customers
Analysis
CatSci expands capabilities to offer expert cGMP analytical development services
CatSci is thrilled to announce the launch of its expert cGMP analytical capabilities in Dagenham, UK
Manufacturing
Catsci welcomes His Majesty’s Lord-Lieutenant in Wales
This special visit was to commemorate CatSci’s monumental achievement in winning The Queen’s Award for Enterprise: International Trade 2022
Manufacturing
CatSci's new partnership with AGC Pharma Chemicals
AGC Pharma Chemicals have more than 40 years of small molecule CDMO and 60 years of API manufacturing experienc
Manufacturing
CatSci invests in oligonucleotides production capability
Oligonucleotides are an emerging modality and an innovative technology offering new therapeutics opportunities to treat previously unmet patients’ needs
Manufacturing
CatSci wins at Bionow Awards
“We are dedicated to continually evolving to support pharmaceutical companies all over the globe and address their CMC demands”
Finance
CatSci opens Dagenham laboratory with analytical focus
The facility has been equipped analytical equipment through a collaboration with Shimadzu Corporation
Subscribe now